Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.
about
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controlsEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesAKAP4 is a circulating biomarker for non-small cell lung cancerBlood-gene expression reveals reduced circadian rhythmicity in individuals resistant to sleep deprivationPeripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapyTranscriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanomaAnalysis of the transcriptome in molecular epidemiology studiesDNA methylation arrays as surrogate measures of cell mixture distribution.Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.Deconvolution of the gene expression profiles of valuable banked blood specimens for studying the prognostic values of altered peripheral immune cell proportions in cancer patientsValidation of methylation biomarkers that distinguish normal colon mucosa of cancer patients from normal colon mucosa of patients without cancer.Use of transcriptomics in understanding mechanisms of drug-induced toxicityIntegrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumorsGene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density.Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer.Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy.Exosomes as divine messengers: are they the Hermes of modern molecular oncology?Making sense of OMICS data in population-based environmental health studies.Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraAn empirical assessment of validation practices for molecular classifiersRNA-stabilized whole blood samples but not peripheral blood mononuclear cells can be stored for prolonged time periods prior to transcriptome analysis.A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection.A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.Peripheral blood gene expression profiles in COPD subjects.Similar source of differential blood mRNAs in lung cancer and pulmonary inflammatory diseases: calls for improved strategy for identifying cancer-specific biomarkersA gene expression signature from peripheral whole blood for stage I lung adenocarcinoma.Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.A robust blood gene expression-based prognostic model for castration-resistant prostate cancerCigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome.Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.Clinical potential of gene mutations in lung cancer.Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis.Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques.The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancerSynergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma.Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system.Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.
P2860
Q24594189-34C3F99F-1A2A-4C1B-BFB5-7040416A1117Q27023830-A28F1C1A-98DF-4C3C-887A-2FF9736B3C37Q28264905-C2AA827C-3699-4F7B-8578-157172FC204BQ28394752-BA9482E8-6D3C-4102-9C73-CB9190CBDB41Q28394867-21FC4ED0-8A67-45D2-B93B-4CFF71BFEDACQ28743603-9B6A706D-F917-406B-B0CF-108BE6C5A766Q28817795-609EF7C2-B26D-44CC-8C51-D8053C81B76BQ30530775-6E5CE7E7-6755-4192-845E-A9FC426F7FCAQ30600084-A2ED063F-1537-4D0C-BA00-405471E8AF56Q33800793-D7FC5659-57DB-4327-B7E9-3D600C702E81Q33859385-48A079F1-EE34-407F-B633-62810C8425AAQ33909001-36E8DAB8-B8AB-4029-A009-C683BB1E8481Q33968879-B25BFC9F-621F-4638-B406-51DB8E21E567Q33992622-E25BA2FE-BA36-484D-B15A-271EED93A484Q34173591-45CDBDDD-CE6B-4962-AB53-B2BF14006F4AQ34222535-C2EE65E4-23BC-46B9-85D0-2BA02DB08AA5Q34464401-868AD1B9-EF0F-4983-BA5B-9E7106D588FEQ34675263-156CFA44-DB8B-4853-A1C0-8447DDFC11F4Q34692003-F3B185FA-0BFE-4474-9C02-BEB9DEC31EC8Q34840130-7B39FE66-3A97-4E80-A6AA-37EC59530435Q34933977-5C926CFB-5EC0-4683-9264-CD2AD2C42D0CQ35069942-E05EC364-CF21-4298-A9D6-9A40681048D3Q35101278-A05E6D5F-C101-4618-8B26-BDCE83DFD3ACQ35108376-6E7490B6-1CBB-44E8-84F1-BE9C95E8D87DQ35131244-B6C528EC-7258-486C-B092-AD1A02E2C01AQ35189082-EF6FFB7F-78E5-41EB-BDC1-5077617A1DF2Q35268621-C2B524A2-AE54-4D87-B531-8A44EF9C51C4Q35281526-7D33690C-0267-4156-BC89-2E9C708F1218Q35391746-1F3B9DD0-C0B6-49EE-8EE7-8041CB17DEAAQ35752837-725BC560-3C53-4CA2-9CB1-3E6629900B54Q36026933-8CF01FE9-B72D-4D75-B72E-D635FFD6A31AQ36101421-488CEC37-BEC2-4BBB-A1C7-44B63BB7E904Q36316009-123517E0-A649-41FD-81D0-C2A9B5655F09Q36316844-AAD14437-750E-4526-88BE-18D716052507Q36628606-92D52ACC-D662-40BF-BA0A-7D2B4AF70792Q36629398-9F094CFD-91A4-4814-899D-6F1550FD9B43Q36730742-B0E467D6-E81D-4A21-AF1E-72E237F08658Q36745834-B01C3938-C2E2-4F00-A7F2-5443D8F8AEDBQ36913743-8844710E-1A6D-42EF-B701-2ADCD0CBBB8EQ36930831-453CF0D7-2A43-4BF2-BD5B-90EDACB96B6F
P2860
Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@ast
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@en
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@nl
type
label
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@ast
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@en
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@nl
prefLabel
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@ast
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@en
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@nl
P2093
P2860
P1433
P1476
Gene expression profiles in pe ...... ith nonmalignant lung disease.
@en
P2093
Andrew V Kossenkov
Anil Vachani
Calen Nichols
Celia Chang
David Speicher
Elena V Nikonova
Elliot Wakeam
John Kucharczuk
Louise C Showe
P2860
P304
P356
10.1158/0008-5472.CAN-09-1378
P407
P577
2009-12-01T00:00:00Z